http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1475795-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d905e55f211f271b3f8f6d8ffe594611 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00 |
| filingDate | 1974-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1977-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1475795-A |
| titleOfInvention | Steroid 21-thioesters |
| abstract | 1475795 Steroid 21-thioesters JOUVEINAL SA 30 May 1974 [30 May 1973] 23992/74 Heading C2U The invention comprises compounds of formula (wherein R 1 is alkyl of at least 4 carbon atoms or p-fluorophenyl; R 2 is H or Me; R 3 is OH or oxo; R 4 is H or F ; and R 5 and R 6 are each H or together represent an extra C 1 -C 2 bond); and their preparation from the corresponding 21- iodo steroids by reaction with R 1 COSM (where M is an alkali metal). 9α-Fluoro-16α-methyl- 11#,17α - dihydroxy - 21 - mercaptopregna - 1,4- diene - 3,20 - dione 21 - trimethylacetate (Ia) per se is disclaimed. Anti-inflammatory oral, parenteral, topical and rectal compositions comprise a compound I or Ia and a carrier. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5420120-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2311290-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4861765-A |
| priorityDate | 1973-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974 |
Total number of triples: 16.